IL6 and metabolic dysfunction-associated steatohepatitis: On the contrary, other authors supported that chronic activation of IL-6 signaling in the liver promoted hepatic IR [187] and that IL-6 deletion (il6−/−) or pharmacological inhibition of IL-6 in mice on MCD diet attenuated NASH [188, 189].